TABLE 4.
Patient‐reported outcomes and change over 8 weeks.
| Variables | Baseline | Post‐intervention | |
|---|---|---|---|
| Median (IQR) | Median (IQR) | p | |
| EORTC QLQ‐C30 | |||
| Global health status | 66.7 (47.9–83.3) | 75.0 (58.3–83.3) | 0.888 |
| Physical functioning | 93.3 (65.0–100.0) | 96.7 (70.0–100.0) | 0.315 |
| Role functioning | 75.0 (29.2–100.0) | 91.7 (62.5–100.0) | 0.306 |
| Emotional functioning | 75.0 (58.3–91.7) | 83.3 (58.3–93.8) | 1.000 |
| Cognitive functioning | 83.3 (62.5–100.0) | 91.7 (62.5–100.0) | 0.279 |
| Social functioning | 66.7 (29.2–100.0) | 83.3 (16.7–100.0) | 0.496 |
| Fatigue | 44.4 (22.2–66.7) | 33.3 (19.4–47.2) | 0.440 |
| Nausea/vomiting | 0.0 (0.0–16.7) | 0.0 (0.0–16.67) | 0.705 |
| Pain | 25.0 (12.5–25.0) | 16.7 (0.0–37.5) | 0.786 |
| Dyspnoea | 0.0 (0.0–33.3) | 16.7 (0.0–41.7) | 0.084 |
| Insomnia | 33.3 (25.0–66.7) | 33.3 (0.0–66.7) | 1.000 |
| Appetite loss | 0.0 (0.0–33.3) | 0.0 (0.0–8.33) | 0.157 |
| Constipation | 33.3 (0.0–33.3) | 0.0 (0.0–33.3) | 0.046 |
| Diarrhoea | 0.0 (0.0–33.3) | 0.0 (0.0–8.3) | 0.705 |
| Financial difficulties | 0.0 (0.0–100.0) | 33.3 (0.0–100.0) | 0.157 |
| ABC Scale, pts | 140.5 (115.0–150.0) | 147.0 (122.3–149.0) | 0.192 |
| IPAQ‐SF | |||
| Physical activity levels a | 516 (363–1292) | 1374 (435–1763) | 0.047 |
| Sedentary behaviour | 3225 (2363–4500) | 2550 (1650–3450) | 0.107 |
Abbreviations: ABC Scale, Activities‐Specific Balance Confidence Scale; EORTC QLQ‐C30, The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; IPAQ‐SF, International Physical Activity Questionnaire–Short Form; IQR, interquartile range.
a
MET‐min/week.